Back
Insmed, Inc. 10K Form
Sell
40
INSM
Insmed, Inc.
Last Price:
$166.55
Seasonality Move:
7.61%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-09 | 10Q | INSM/Insmed, Inc. Quarterly |
| 2023-10-26 | 10Q | INSM/Insmed, Inc. Quarterly |
| 2023-08-03 | 10Q | INSM/Insmed, Inc. Quarterly |
| 2023-05-04 | 10Q | INSM/Insmed, Inc. Quarterly |
| 2022-10-27 | 10Q | INSM/Insmed, Inc. Quarterly |
| 2022-08-04 | 10Q | INSM/Insmed, Inc. Quarterly |
Receive INSM News And Ratings
See the #1 stock for the next 7 days that we like better than INSM
INSM Financial Statistics
Sales & Book Value
| Annual Sales: | $363.7M |
|---|---|
| Cash Flow: | $-222.2M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $4.45 |
| Price / Book: | 37.57 |
Profitability
| EPS (TTM): | -6.18120 |
|---|---|
| Net Income (TTM): | $-1.2B |
| Gross Margin: | $272.9M |
| Return on Equity: | -193.23% |
| Return on Assets: | -55.21% |
Insmed, Inc. Earnings Forecast
Key Insmed, Inc. Financial Ratios
-
The Gross Profit Margin over the past 26 years for INSM is 75.04%.
-
The Selling, General & Administrative Expenses for INSM have been equal to 126.78% of Gross Profit Margin.
-
The Research & Development expenses have been 164.52% of Revenue.
-
The Net Earning history of INSM is -251.24% of Total Revenues.
-
Per Share Earnings over the last 26 years have been positive in 9 years.
Insmed, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | INSM |
| CUSIP: | 457669 |
| Website: | insmed.com |
Debt
| Debt-to-Equity Ratio: | 0.79 |
|---|---|
| Current Ratio: | 4.63 |
| Quick Ratio: | 4.18 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
INSM Technical Analysis vs Fundamental Analysis
Sell
40
Insmed, Inc. (INSM)
is a Sell
Is Insmed, Inc. a Buy or a Sell?
-
Insmed, Inc. stock is rated a SellThe current Insmed, Inc. [INSM] share price is $166.55. The Score for INSM is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.